← SynDRA
ZIBOTENTAN
SynDRA canonical compound SYN0025811 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EDNRA |
|---|
| Mechanism of action | Endothelin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Endothelin receptor antagonist
- EDNRA ANTAGONIST
- Endothelin receptor ET-A antagonist
Cross-references
Synonyms
- ZD-4054
- ZD4054
- ZD4054, Zibotentan
- Zibotentan (JAN/INN)
- Trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid
- N-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide
- Zd 4054
- zibotentanum
- RefChem:904857
- DTXCID20817970
- Zibotentan (ZD4054)
- C19H16N6O4S
- Zibotentan (ZD4054 )
- MFCD09955343
- Zibotentan [USAN:INN:JAN]
- UNII-8054MM4902
- Zibotentan,ZD4054
- ZibotentanZD4054?
- ZIBOTENTAN [MI]
- ZIBOTENTAN [INN]
- ZIBOTENTAN [JAN]
- ZIBOTENTAN [USAN]
- ZIBOTENTAN [MART.]
- ZD4054 Form 1
- A1D5L
- ZIBOTENTAN [WHO-DD]
- MLS006011121
- SCHEMBL847090
- Zibotentan (JAN/USAN/INN)
- GTPL3539
- orb1687464
- SCHEMBL29350705
- SCHEMBL29706386
- Zibotentan, >=98% (HPLC)
- CHEBI:94573
- GLXC-01923
- HMS3654H10
- BDBM50532593
Look up ZIBOTENTAN in the interactive SynDRA portal →